[1]
Best, M. et al. 2018. Use of Anti-transcriptional Intermediary Factor-1 Gamma Autoantibody in Identifying Adult Dermatomyositis Patients with Cancer: A Systematic Review and Meta-analysis. Acta Dermato-Venereologica. 99, 3 (Dec. 2018), 256–262. DOI:https://doi.org/10.2340/00015555-3091.